A comprehensive view of pfizer inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

European Commission approves Pfizer's DURVEQTIX® gene therapy for hemophilia B; reduces bleeds post-treatment with a median annualized bleed rate of zero bleeds after up to four years of follow-up
Published: July 25, 2024 by Pfizer Inc.
Pfizer advances hemophilia A gene therapy and honors cancer pharmacogenomics research; company also reduces greenhouse gas emissions in Spain and engages Greek pharmacy students for educational visit
Published: July 25, 2024 by Industry Intelligence Inc.
Pfizer announces positive Phase 3 results for hemophilia A gene therapy giroctocogene fitelparvovec; trial shows a significant reduction in mean total annualized bleeding rate
Published: July 24, 2024 by Pfizer Inc.
Patent Issued for Selectively vented biological assay devices and associated methods (USPTO 12023671)
Published: July 24, 2024 by Biotech Business Daily
Patent Issued for Devices and methods for modifying optical properties (USPTO 12023665)
Published: July 23, 2024 by Biotech Business Daily

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count